Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019, dated December 24, 2019, GKB Ophthalmics has informed that the Audit Committee in their meeting held on September 07, 2020, has reviewed the utilisation of funds which were raised by means of preferential allotment and noted that there is no deviation or variation in the use of proceeds, during the quarter ended June 30, 2020.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Lenskart Solutions | 489.50 |
| Poly Medicure | 1651.20 |
| Laxmi Denta | 214.95 |
| Nureca Ltd. | 289.30 |
| Hemant Surgical Inds | 301.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: